Cysteine protease inhibitors

Details for Australian Patent Application No. 2006268752 (hide)

Owner Medivir AB

Inventors Tozer, Matt; Parkes, Kevin; Grabowska, Urszula; Tickle, David

Agent Davies Collison Cave

Pub. Number AU-A-2006268752

PCT Pub. Number WO2007/006716

Priority 0513839.1 07.07.05 GB

Filing date 6 July 2006

Wipo publication date 18 January 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 19/00 (2006.01) Drugs for skeletal disorders

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/006716 Priority application(s): WO2007/006716

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268765-Asymmetric reduction of 1,1,1-trifluoroacetone

2006268749-Method for controlling bark beetle populations by controlling bark beetle antagonists